Ch. 13.4: References and Image Credits

References

Begun, A.L. (2020). Introduction to psychoactive substances. In A.L. Begun & M.M. Murray, (Eds.), Routledge handbook of social work and addictive behavior. London: Routledge.

Brandlistuen, R.E., Ystrom, E., Herńandez-Diaz, S., Skurtveit, S., Selmer, R.M., Handal, M., & Nordeng, H. (2017). Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study. PLos One, 12(7), e0181042. Doi:10.1371/journal.pone.0181042

Chakraborty, K., Neogi, R., & Basu, D. (2011). Club drugs: Review of the ‘rave’ with a note of concern for the Indian scenario. Indian Journal of Medical Research, 133(5), 594-604.

Dupont, R.L., & Dupont, C.M. (2005). Sedative/hypnotics and benzodiazepines. In R.J. Frances, S.I. Miller, & A.H. Mack, (Eds.), Clinical textbook of addictive disorders, third ed., (pp. 219-242). NY: Guilford Press.

McElhatton, P.R. (1994). The effects of benzodiazepine use during pregnancy and lactation. Reproductive Toxicology, 8(6), 461-475.

National Institute on Drug Abuse (NIDA). (2018). Prescription CNS depressants. National Institutes of Health, U.S. Department of Health and Human Services. Retrieved from https://www.drugabuse.gov/publications/drugfacts/prescription-cns-depressants

Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). National Survey on Drug Use and Health (NSDUH) 2018 detailed tables. Retrieved from https://www.samhsa.gov/data/report/2018-nsduh-detailed-tables